Glycoprotein glycosylation and cancer progression

Biochimica et Biophysica Acta - General Subjects

Volumn 1473, Issue 1, 1999, Pages 21-34

  Dennis, James W ^a,b   Granovsky, Maria ^a,b   Warren, Charles E ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adhesion; Cancer; GlcNAc TV; Metastasis; Motility; Receptors

Indexed keywords

GLYCAN DERIVATIVE; N ACETYLGLUCOSAMINYLTRANSFERASE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; CANCER GROWTH; DISEASE ASSOCIATION; GENE EXPRESSION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; REVIEW; SIALYLATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

AMINO SUGARS; ANIMALS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOLIPIDS; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASM METASTASIS; NEOPLASMS; POLYSACCHARIDES; RECEPTORS, ANTIGEN, T-CELL; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; MUS MUSCULUS;

EID: 0032714567     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(99)00167-1     Document Type: Review

References (112)

1. Hodgkin J., Horvitz H.R., Jasny B.R., Kimble J. C. elegans: Sequence to biology. Science. 282:1998;2011-2046.
2. Sternberg P.W., Han M. Genetics of RAS signaling in C. elegans. Trends Genet. 14:1998;466-472.
3. Schachter H. Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. Biochem. Cell Biol. 64:1986;163-181.
4. van den Eijnden D.H., Koenderman A.H.L., Schiphorst W.E.C.M. Biosynthesis of blood group i-active polylactosaminoglycans. J. Biol. Chem. 263:1988;12461-12465.
5. Cummings R.D., Kornfeld S. The distribution of repeating Gal β1-4GlcNAc β1-3 sequences in asparagine-linked oligosaccharides of the mouse lymphoma cell line BW5147 and PHAR 2.1. J. Biol. Chem. 259:1984;6253-6260.
6. Yousefi S., Higgins E., Doaling Z., Hindsgaul O., Pollex-Kruger A., Dennis J.W. Increased UDP-GlcNAc:Gal β1-3GalNAc-R (GlcNAc to GalNAc) β1-6 N-acetylglucosaminyltransferase activity in transformed and metastatic murine tumor cell lines: control of polylactosamine-synthesis. J. Biol. Chem. 266:1991;1772-1783.
7. Holmes E.H., Hakomori S.-I., Ostrander G.K. Synthesis of type 1 and 2 lacto series glycolipid antigens in human colonic adenocarcinoma and derived cell lines is due to activation of a normally unexpressed β1-3N-acetylglucosaminyltransferase. J. Biol. Chem. 262:1987;15649-15657.
8. Wang W.C., Lee N., Aoki D., Fukuda M.N., Fukuda M. The poly-N-acetyllactosamines attached to lysosomal membrane glycoproteins are increased by the prolonged association with the Golgi complex. J. Biol. Chem. 266:1991;23185-23190.
9. Prieto P.A., Larsen R.D., Cho M., Rivera H.N., Shilatifard A., Lowe J.B., Cummings R.D., Smith D.F. Expression of human H-type α1,2-fucosyltransferase encoding for blood group H (0) antigen in Chinese hamster ovary cells. J. Biol. Chem. 272:1997;2089-2097.
10. Rademacher T.W., Parekh B., Dwek R.A. Glycobiology. Annu. Rev. Biochem. 57:1988;785-838.
11. 4-4GalNAcβ1,4GlcNAcβ1,Manα that mediates rapid clearance of lutropin. Cell. 67:1991;1103-1110.
12. Takeuchi M., Kobata A. Structures and functional roles of the sugar chains of human erythropoietins. Glycobiology. 1:1991;337-346.
13. Skelton T.P., Zeng C., Nocks A., Stamenkovic I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J. Cell Biol. 140:1998;431-446.
14. Diamond M.S., Staunton D.E., Martin S.D., Springer T.A. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell. 65:1991;961-971.
15. McEvoy L.M., Sun H., Frelinger J.G., Butcher E.C. Anti-CD43 inhibition of T cell homing. J. Exp. Med. 185:1997;1493-1498.
16. Kornfeld R., Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54:1985;631-664.
17. Gomez L., Chrispeels M.J. Complementation of an Arabidopsis thaliana mutant that lacks complex asparagine-linked glycans with the human cDNA encoding N-acetylglucosaminyltransferase I. Proc. Natl. Acad. Sci. USA. 91:1994;1829-1833.
18. Metzler M., Gertz A., Sarkar M., Schachter H., Schrader J.W., Marth J.D. Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development. EMBO J. 13:1994;2056-2065.
19. Ioffe E., Stanley P. Mice lacking N-acetylglucosaminyltransferase I activity die at mid-gestation, revealing an essential role for complex or hybrid N-linked carbohydrates. Proc. Natl. Acad. Sci. USA. 91:1994;728-732.
20. Sandros J., Rozdzinski E., Zheng J., Cowburn D., Tuomanen E. Lectin domains in the toxin of Bordetella pertussis: selectin mimicry linked to microbial pathogenesis. Glycoconjugate J. 11:1994;501-506.
21. Pritchett T.J., Brossmer R., Rose U., Paulson J.C. Recognition of monovalent sialosides by influenza virus H3 hemagglutinin. Virology. 160:1987;502-506.
22. Dennis J.W., Granovsky M., Warren C.E. Protein glycosylation in development and disease. BioEssays. 21:1999;412-421.
23. Asano M., Furukawa K., Kido M., Matsumoto S., Umesaki Y., Kochibe N., Iwakura Y. Growth retardation and early death of β1,4-galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells. EMBO J. 16:1997;1850-1857.
24. Priatel J.J., Sarkar M., Schachter H., Marth J.D. Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction. Glycobiology. 7:1997;45-56.
25. Shoreibah M., Perng G.-S., Adler B., Weinstein J., Basu R., Cupples R., Wen D., Browne J.K., Buckhaults P., Fregien N., Pierce M. Isolation, characterization, and expression of cDNA encoding N-acetylglucosaminyltransferase V. J. Biol. Chem. 268:1993;15381-15385.
26. B., Korczak, T. Le, S. Elowe, J.W. Dennis, Structure function analysis of rat N-acetylglucosaminyltransferase V. Glycoconjugate J., S123 (1997) Abstract 346.
27. Weinstein J., Sundaram S., Wang X., Delgado D., Basu R., Stanley P. A point mutation causes mistargeting of golgi GlcNAc-TV in the Lec4A Chinese hamster ovary glycosylation mutant. J. Biol. Chem. 271:1996;27462-27469.
28. Granovsky M., Fode C., Warren C.E., Campbell R.M., Marth J.D., Pierce M., Fregien N., Dennis J.W. GlcNAc-transferase V and core 2 GlcNAc-transferase expression in the developing mouse embryo. Glycobiology. 5:1995;797-806.
29. Yamashita K., Ohkura T., Tachibana Y., Takasaki S., Kobata A. Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. J. Biol. Chem. 259:1984;10834-10840.
30. Yamashita K., Tachibana Y., Ohkura T., Kobata A. Enzymatic basis for the structural changes of asparagine-linked sugar chains of membrane glycoproteins of baby hamster kidney cells induced by polyoma transformation. J. Biol. Chem. 260:1985;3963-3969.
31. Easton E.W., Bolscher J.G.M., van den Eijnden D.H. Enzymatic amplification involving glycosyltransferases forms the basis for the increased size of asparagine-linked glycans at the surface of NIH 3T3 cells expressing the N-ras proto-oncogene. J. Biol. Chem. 266:1991;21674-21680.
32. Lu Y., Chaney W. Induction of N-acetylglucosaminyltransferase V by elevated expression of activated or proto-Ha-ras oncogenes. Mol. Cell. Biochem. 122:1993;85-92.
33. Dennis J.W., Laferte S., Waghorne C., Breitman M.L., Kerbel R.S. β 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science. 236:1987;582-585.
34. Dennis J.W., Kosh K., Bryce D.-M., Breitman M.L. Oncogenes conferring metastatic potential induce increased branching of Asn-linked oligosaccharides in rat2 fibroblasts. Oncogene. 4:1989;853-860.
35. Warren L., Critchley D., Macpherson I. Surface glycoproteins and glycolipids of chicken embryo cells transformed by a temperature-sensitive mutant of rous sarcoma virus. Nature. 235:1972;275-278.
36. van Beek W., Tulp A., Bolscher J., Blanken G., Roozendaal K., Egbers M. Transient versus permanent expression of cancer-related glycopeptides on normal versus leukemic myeloid cells coinciding with marrow egress. Blood. 63:1984;170-176.
37. Fernandes B., Sagman U., Auger M., Demetriou M., Dennis J.W. β1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res. 51:1991;718-723.
38. Cummings R.D., Kornfeld S. Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectin. J. Biol. Chem. 257:1982;11230-11234.
39. Seelentag W.K., Li W.P., Schmitz S.F., Metzger U., Aeberhard P., Heitz P.U., Roth J. Prognostic value of beta 1,6-branched oligosaccharides in human colorectal carcinoma. Cancer Res. 58:1998;5559-5564.
40. Takano R., Nose M., Nishihira I., Kyogoku M. Increase of β1-6-branched oligosaccharides in human esophageal carcinomas invasive against surrounding tissue in vivo and in vitro. Am. J. Pathol. 137:1990;1007-1011.
41. Hussain S.P., Harris C.C. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res. 58:1998;4023-4037.
42. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677.
43. Pozzatti R., Muschel R., Williams J., Padmanabhan R., Howard B., Liotta L., Khoury G. Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials. Science. 232:1986;223-225.
44. Pohl J., Goldfinger N., Radler-Pohl A., Rotter V., Schirrmacher V. p53 increases experimental metastatic capacity of murine carcinoma cells. Mol. Cell. Biol. 8:1988;2078-2081.
45. Frixen U.H., Behrens J., Sachs M., Eberle G., Voss B., Warda A., Lochner D., Birchmeier W. E-Cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113:1991;173-185.
46. Hakomori S.-I. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 56:1996;5309-5318.
47. Kobata A. A retrospective and prospective view of glycopathology. Glycoconjugate J. 15:1998;323-331.
48. Wasylyk B., Hagman J., Gutierrez-Hartmann A. Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathways. Trends Biochem. Sci. 23:1998;213-216.
49. Saez E., Rutberg S.E., Mueller E., Oppenheim H., Smoluk J., Yuspa S.H., Spiegelman B.M. c-fos is required for malignant progression of skin tumors. Cell. 82:1995;721-732.
50. Saito H., Gu J., Nishikawa A., Ihara Y., Fujii J., Kohgo Y., Taniguchi N. Organization of the human N-acetylglucosaminyltransferase V gene. Eur. J. Biochem. 233:1995;18-26.
51. Buckhaults P., Chen L., Fregien N., Pierce M. Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene. J. Biol. Chem. 272:1997;19575-19581.
52. Galang C.K., Garcia-Ramirez J., Solski P.A., Westwick J.K., Der C.J., Neznanov N.N., Oshima R.G., Hauser C.A. Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. J. Biol. Chem. 271:1996;7992-7998.
53. Chen L., Zhang W., Fregien N., Pierce M. The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products. Oncogene. 17:1998;2087-2093.
54. Miyoshi E., Nishikawa A., Ihara Y., Gu J., Sugiyama T., Hayashi N., Fusamoto H., Kamada T., Taniguchi N. N-Acetylglucosaminyltransferase III and V messenger RNA levels in LEC rats during hepatocarcinogenesis. Cancer Res. 53:1993;3899-3902.
55. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ulrich A., McGuire W.L. Human breast cancer: correlation of relapse and survival with amplification of the Her-2/neu oncogene. Science. 235:1987;177-182.
56. Demetriou M., Nabi I.R., Coppolino M., Dedhar S., Dennis J.W. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J. Cell Biol. 130:1995;383-392.
57. Seberger P.J., Chaney W.G. Control of metastasis by asn-linked, β1-6 branched oligosaccharides in mouse mammary cancer cells. Glycobiology. 9:1999;235-241.
58. Yoshimura M., Nishikawa A., Ihara Y., Taniguchi S., Taniguchi N. Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase II gene transfection. Proc. Natl. Acad. Sci. USA. 92:1995;8753-8758.
59. Yoshimura M., Ihara Y., Matsuzawa Y., Taniguchi N. Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J. Biol. Chem. 271:1996;13811-13815.
60. Sheng Y., Yoshimura M., Inoue S., Oritani K., Nishiura T., Yoshida H., Ogawa M., Okajima Y., Matsuzawa Y., Taniguchi N. Remodeling of glycoconjugates on CD44 enhances cell adhesion to hyaluronate, tumor growth and metastasis in B16 melanoma cells expressing β1,4-N-acetylglucosaminyltransferase III. Int. J. Cancer. 73:1997;850-858.
61. Birchmeier W. E-cadherin as a tumor (invasion) suppressor gene. BioEssays. 17:1995;97-99.
62. Schmits R., Filmus J.G.N., Senaldi G., Kiefer F., Kundig T., Wakeham A., Shahinian A., Catzavelos C., Rak J., Furlonger C., Zakarian A., Simard J.J.L., Ohashi P.S., Paige C.J., Guiterrez-Ramos J.C., Mak T.W. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood. 90:1997;2217-2233.
63. Rebbaa A., Yamamoto H., Saito T., Meuillet E., Kim P., Kersey D.S., Bremer E.G., Taniguchi N., Moskal J.R. Gene transfection-mediated overexpression of β1,4-N-acetylglucosamine bisecting oligosaccharides in glioma cell line U373 MG inhibits epidermal growth factor receptor function. J. Biol. Chem. 272:1997;9275-9279.
64. Ihara Y., Sakamoto Y., Mihara M., Shimizu K., Taniguchi N. Overexpression of N-acetylglucosaminyltransferase III disrupts the tyrosine phosphorylation of Trk with resultant signaling dysfunction in PC12 cells treated with nerve growth factor. J. Biol. Chem. 272:1997;9629-9634.
65. Tan P.B.O., Kim S.K. Signaling specificity: the RTK/RAS/MAP kinase pathway in metazoans. Trends Genet. 15:1999;145-149.
66. Lemaire S., Derappe C., Michalski J.C., Aubery M., Neel D. Expression of β1-6-branched N-linked oligosaccharides is associated with activation in human T4 and T8 cell populations. J. Biol. Chem. 269:1994;8069-8074.
67. Lu Y., Pelling J.C., Chaney W.G. Tumor cell surface beta 1-6 branched oligosaccharides and lung metastasis. Clin. Exp. Metastasis. 12:1994;47-54.
68. Guy C.T., Cardiff R.D., Muller W.J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12:1992;954-961.
69. Guy C.T., Muthuswamy S.K., Cardiff R.D., Soriano P., Muller W.J. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev. 8:1994;23-32.
70. Cheng A.M., Saxton T.M., Sakai R., Kulkarni S., Mbamalu G., Vogel W., Tortorice C.G., Cardiff R.D., Cross J.C., Muller W.J., Pawson T. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell. 95:1999;793-803.
71. Webster M.A., Hutchinson J.N., Rauh M.J., Muthuswamy S.K., Anton M., Tortorice C.G., Cardiff R.D., Graham F.L., Hassell J.A., Muller W.J. Requirement for both Shc and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol. Cell. Biol. 18:1998;2344-2359.
72. Illc D., Furuta Y., Kanazawa S., Takeda N., Sobue K., Nakatsuji N., Nomura S., Fujimoto J., Okada M., Yamamoto T., Aizawa S. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature. 377:1995;539-544.
73. Schaller M.D., Otey C.A., Hildebrand J.D., Parsons J.T. Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains. J. Cell. Biol. 130:1995;1181-1187.
74. Leppa S., Heino J., Jalkanen M. Increased glycosylation of beta 1 integrins affects the interaction of transformed S115 mammary epithelial cells with laminin-1. Cell Growth Differ. 6:1995;853-861.
75. Braut-Boucher F., Font J., Pichon J., Paulin Y., Boukhelifa M., Aubery M., Derappe C. T lymphocytes from sezary syndrome patients express beta1 integrins whose β1,6-branched N-linked oligosaccharides reflect their adhesive capacity. Leuk. Res. 22:1998;947-952.
76. Bhaumik M., Harris T., Sundaram S., Johnson L., Guttenplan J., Rogler C., Stanley P. Progression of hepatic neoplasms in severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: evidence for a glycoprotein factor that facilitates hepatic tumor progression. Cancer Res. 58:1998;2881-2887.
77. Shimodaira K., Nakayama J., Nakamura N., Hasebe O., Katsuyama T., Fukuda M. Carcinoma-associated expression of core 2 β-1,6-N-Acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression. Cancer Res. 57:1997;5201-5206.
78. Bresalier R.S., Niv Y., Byrd J.C., Duh Q.Y., Toribara N.W., Rockwell R.W., Dahiya R., Kim Y.S. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J. Clin. Invest. 87:1991;1037-1045.
79. Dennis J.W., Donaghue T., Florian M., Kerbel R.S. Apparent reversion of stable in vivo genetic markers detected in tumor cells from spontaneous metastases. Nature. 292:1981;242-245.
80. Kerbel R.S., Lagarde A.E., Dennis J.W., Donaghue T.P. Spontaneous fusion in vivo between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor. Mol. Cell. Biol. 3:1983;523-538.
81. Dennis J.W., Laferte S. Co-reversion of a lectin-resistant mutation and non-metastatic phenotype in murine tumor cells. Int. J. Cancer. 38:1986;445-450.
82. Ishikawa M., Dennis J.W., Kerbel R.S. Isolation and characterization of spontaneous wheat germ agglutinin-resistant human melanoma mutants displaying remarkable different metastatic profiles in nude mice. Cancer Res. 48:1988;665-670.
83. Ohannesian D.W., Lotan D., Thomas P., Jessup J.M., Fukuda M., Gabius H.-J., Lotan R. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Res. 55:1995;2191-2199.
84. Beuth J., Ko H.L., Oette K., Pulverer G., Roszkowski K., Uhlenbruck G. Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose. J. Cancer Res. Clin. Oncol. 113:1987;51-55.
85. Cornil I., Kerbel R.S., Dennis J.W. Tumor cell surface β1-4 linked galactose binds to lectin(s) on microvascular endothelial cells and contributes to organ colonization. J. Cell Biol. 111:1990;773-782.
86. Takano R., Muchmore E.A., Dennis J.W. Sialylation and malignant potential in tumor cell glycosylation mutants. Glycobiology. 4:1994;665-674.
87. Finne J., Burger M.M., Prieels J.P. Enzymatic basis for a lectin resistant phenotype: increase in a fucosyltransferase in mouse melanoma cells. J. Cell Biol. 92:1982;277-282.
88. Dennis J.W. Different metastatic phenotypes in two genetic classes of WGA-resistant tumor cell mutants. Cancer Res. 46:1986;4594-4600.
89. Shaw L., Yousefi S., Dennis J.W., Schauer R. CMP-N-acetylneuraminic acid hydroxylase activity determines the wheat germ agglutinin-binding phenotype in two mutants of the lymphoma cell line MDAY-D2. Glycoconjugate. 8:1991;434-441.
90. Le Marer N., Stéhelin D. High α2,6-sialylation of N-acetyllactosamine sequences in ras-transformed rat fibroblasts correlates with high invasive potential. Glycobiology. 5:1995;219-226.
91. X-related antigen expression in human malignant and non-malignant colonic tissue. Cancer Res. 46:1986;2627-2632.
92. Mannori G., Crottet P., Cecconi O., Hanasaki K., Aruffo A., Nelson R.M., Varki A., Bevilacqua M.P. Differential coloncancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins. Cancer Res. 55:1995;4425-4431.
93. x antigen in liver metastases of human colorectal carcinoma. Cancer Res. 49:1989;6883-6888.
94. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte migration: the multistep paradigm. Cell. 76:1994;301-314.
95. Li F., Wilkins P.P., Crawley S., Weinstein J., Cummings R.D., McEver R.P. Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin. J. Biol. Chem. 271:1996;3255-3264.
96. Ito H., Hiraiwa N., Sawada-Kasugai M., Akamatsu S., Tachikawa T., Kasai Y., Akiyama S., Ito K., Takagi H., Kannagi R. Altered mRNA expression of specific molecular species of fucosyl- and sialyl-transferases in human colorectal cancer tissues. Int. J. Cancer. 71:1999;556-564.
97. Maly P., Thall A.D., Petryniak B., Rogers C.E., Smith P.L., Marks R.M., Kelly R.J., Gersten K.M., Cheng G., Saunders T.L., Camper S.A., Camphausen R.T., Sullivan F.X., Isogai Y., Hindsgaul O., von Andrian U.H., Lowe J.B. The α(1,3)fucosyltransferase, Fuc-TVII, controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell. 86:1996;643-653.
98. Biancone L., Araki M., Araki K., Vassalli P., Stamenkovic I. Redirection of tumor metastasis by expression of E-selectin in vivo. J. Exp. Med. 183:1996;581-587.
99. Jamjoom Z.A., Jamjoom A.B., Sulaiman A.H., Naim-Ur-Rahman A.R.A. Systemic metastasis of medulloblastoma through vetriculoperitoneal shunt report of a case and critical analysis of the literature. Surg. Neurol. 40:1993;403-410.
100. Yagel S., Feinmesser R., Waghorne C., Lala P.K., Breitman M.L., Dennis J.W. Evidence that β1-6 branched Asn-linked oligosaccharides on metastatic tumor cells facilitate invasion of basement membranes. Int. J. Cancer. 44:1989;685-690.
101. Korczak B., Dennis J.W. Inhibition of N-linked oligosaccharide processing in tumor cells is associated with enhanced tissue inhibitor of metalloproteinases (TIMP) gene expression. Int. J. Cancer. 53:1993;634-639.
102. Seftor R.E.B., Seftor E.A., Grimes W.J., Liotta L.A., Stetler-Stevenson W.G., Welch D.R., Hendrix M.J.C. Human melanoma cell invasion is inhibited in vitro by swainsonine and deoxymannojirimycin with a concomitant decrease in collagenase IV expression. Melanoma Res. 1:1991;43-54.
103. Kanayama H., Yokota K., Kurokawa Y., Murakami Y., Nishitani M., Kagawa S. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer. 82:1998;1359-1366.
104. Goss P.E., Baker M.A., Carver J.P., Dennis J.W. Inhibitors of carbohydrate processing: a new class of anticancer agents. Clin. Cancer Res. 1:1995;935-944.
105. Goss P.E., Baptiste J., Fernandes B., Baker M., Dennis J.W. A study of swainsonine in patients with advanced malignancies. Cancer Res. 54:1994;1450-1457.
106. Goss P.E., Reid C.L., Bailey D., Dennis J.W. Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies. Clin. Cancer Res. 3:1997;1077-1086.
107. Romero P.A., Herscovics A. Transfer of non-glucosylated oligosaccharides from lipid to protein in mammalian cells. J. Biol. Chem. 261:1986;15936-15940.
108. Palecek S.P., Loftus J.C., Ginsberg M.H., Lauffenburger D.A., Horwitz A.F. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature. 385:1997;537-540.
109. Kobata A. Structures, function, and transformational changes of the sugar chains of glycohormones. J. Cell Biochem. 37:1988;79-90.
110. Perillo N.L., Marcus M.E., Baum L.G. Galectins versatile modulators of cell adhesion, cell proliferation, and cell death. J. Mol. Med. 76:1998;402-412.
111. Tedder T.F., Tuscano J., Sato S., Kehrl J.H. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu. Rev. Immunol. 15:1997;481-504.
112. Hennet T., Chui D., Paulson J.C., Marth J.D. Immune regulation by the ST6Gal sialytransferase. Proc. Natl. Acad. Sci. USA. 95:1998;4504-4509.